AMMM Focus Sessions - Call for Papers 2025
Platform for Discussing Defined Topics
Focus sessions will be incorporated into the scientific program of AMMM. These sessions aim to provide a dedicated platform for discussing clearly defined topics related to medical additive manufacturing. The goal is to gather relevant presentations and discussions within a focused time slot. Typically, the focus sessions consist of 6 presentations that revolve around a particular subject or theme of AMMM. These presentations are carefully selected to ensure they align with the session's topic and contribute to a comprehensive discussion on the subject matter. The duration allocated for each focus session is 90 minutes. You may apply for inclusion in a focus session with your submission as part of the submission process: https://www.ammm.science/submissions
Call for Papers
Focus Session 1: Regulatory Challenges in Additive Manufacturing of Medical Devices
N.N., Life Science Nord, Germany
The approval of additively manufactured medical devices poses unique regulatory challenges due to the complexity of additive manufacturing (AM) processes, material variations, and patient-specific adaptations. Regulatory frameworks, such as those of the FDA and MDR, require robust validation strategies to ensure safety, efficacy, and reproducibility. This session will explore key regulatory requirements, challenges in certification, and best practices for compliance. Experts will discuss risk assessment, quality assurance, and documentation strategies, providing insights into accelerating market approval while maintaining regulatory compliance. Attendees will gain a comprehensive understanding of navigating the evolving regulatory landscape of AM medical devices.
Focus Session 2: 3D Printing in the Era of Critical-Sized Bone Defect Treatment
Dr. Marie-Luise Wille, Queensland University of Technology, Australia
Bone defects caused by trauma, cancer, or infection, are problematic for surgeons and patients alike. Critical-sized bone defects will not heal over one’s lifetime without (surgical) intervention. Current treatment options have significant limitations and a strong demand for clinically translatable alternatives, such as scaffold-guided bone regeneration (SGBR). This focus session will explore this new concept and the requirements for a successful bench to bedside translation, incorporating all aspects of the scaffold design and printing process as well as the patients’ journey from the first diagnosis to rehabilitation.